Could the inhibition of IL-17 or IL-18 be a potential therapeutic opportunity for gastric cancer?
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Australian National Health and Medical Research Council (1080498, 1098643)
- Victorian State Government Operational Infrastructure Support
- Victorian Cancer Agency Fellowship
- WEHI Centenary Fellowship
This publication has 156 references indexed in Scilit:
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestineNature, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Functional Specialization of Interleukin-17 Family MembersImmunity, 2011
- Interleukin-26: An IL-10-related cytokine produced by Th17 cellsCytokine & Growth Factor Reviews, 2010
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cellsNature Immunology, 2008
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in MiceCancer Cell, 2008
- Structure of IL-22 Bound to Its High-Affinity IL-22R1 ChainStructure, 2008
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000